Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior

Research in Social and Administrative Pharmacy

Volumn 7, Issue 4, 2011, Pages 369-382

  Gavaza, Paul ^a   Brown, Carolyn M ^b   Lawson, Kenneth A ^b   Rascati, Karen L ^b   Wilson, James P ^b   Steinhardt, Mary ^b  

^a Appalachian College of Pharmacy   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

ADR reporting; Adverse drug events; Attitude; Drug and patient safety; Pharmacists; Pharmacovigilance; Spontaneous reporting

Indexed keywords

DRUG;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; UNITED STATES;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; PHARMACISTS; QUESTIONNAIRES; TEXAS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 82455210452     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2010.09.001     Document Type: Article

References (86)

1. Meadows M. Why drugs get pulled off the market. FDA Consum 2002, 36:11-17.
2. Lawton R., Parker D. Barriers to incident reporting in a healthcare system. Qual Saf Health Care 2002, 11(1):15-18.
3. Cullen D.J., Bates D.W., Small S.D., et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995, 21(10):541-548.
4. Barach P., Smith B.J. Reporting and preventing medical mishaps: lessons from non-medical near miss reporting system. Br Med J 2000, 320(7237):759-763.
5. Scott H., Rosenbaum S., Waters W., et al. Rhode Island physicians' recognition and reporting of adverse drug reactions. R I Med J 1987, 70(7):311-316.
6. Suh D., Woodall B., Shin S., et al. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000, 34(12):1373-1379.
7. Nebeker J.R., Hoffman J.M., Weir C.R., et al. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005, 165(10):1111-1116.
8. Al-Tajir G.K., Kelly W.N. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother 2005, 39(7-8):1169-1174.
9. Dos Santos D.B., Coelho H.L. Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf 2005, 15(9):635-640.
10. Dormann H., Neubert A., Criegee-Rieck M., et al. Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 2004, 255(6):653-663.
11. Classen D.C., Pestotnik S.L., Evans R.S., et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 2007, 266(20):2847-2851.
12. Evans R.S., Pestotnik S.L., Classen D.C., et al. Development of a computerized adverse drug event monitor. Proc Annu Symp Comput Appl Med Care 1991, 23-27.
13. Phansalkar S., Hoffman J.M., Nebeker J.R., et al. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm 2007, 64(8):842-849.
14. Holden R.J., Karsh B.T. A review of medical error reporting system design considerations and a proposed cross-level systems research framework. Hum Factors 2007, 49(2):257-276.
15. Karsh B.T., Escoto K.H., Beasley J.W., et al. Toward a theoretical approach to medical error reporting system research and design. Appl Ergon 2006, 37(3):283-295.
16. Irujo M., Beitia G., Bes-Rastrollo M., et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf 2007, 30(11):1073-1082.
17. van Grootheest A.C., Mes K., de Jong-van den Berg L.T.W. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract 2002, 10(4):267-272.
18. Bawazir S.A. Attitude of community pharmacists in Saudi Arabia towards adverse drug reaction reporting. Saudi Pharm J 2006, 14(1):75-83.
19. Wu J.-R., Moser D.K., Lennie T.A., et al. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am 2008, 43(1):133-153.
20. Godin G., Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot 1996, 11(2):87-98.
21. Millstein S.G. Utility of the theories of reasoned action and planned behavior for predicting physician behavior: a prospective analysis. Health Psychol 1996, 15(5):398-402.
22. Feng J.-Y., Wu Y.-W.B. Nurses' intention to report child abuse in Taiwan: a test of the theory of planned behavior. Res Nurs Health 2005, 28(4):337-347.
23. Coleman C.-L. Examining influences of pharmacists' communication with consumers about antibiotics. Health Commun 2003, 15(1):79-99.
24. Mashburn JH, Brown CM, Shepherd MD, et al. Using the Theory of Planned Behavior to Predict Texas Community Pharmacists' Willingness to Provide Sterile Syringes to Known or Suspected Intravenous Drug Users [dissertation]. Austin: The University of Texas at Austin; 2003.
25. Armitage C.J., Conner M. Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Soc Psychol 2001, 40(4):471-499.
26. Conner M., Sparks P. The theory of planned behaviour and health behaviours. Predicting Health Behaviour 1996, 121-162. Open University Press, Buckingham, UK. M. Conner, P. Norman (Eds.).
27. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50(2):179-211.
28. Beck L., Ajzen I. Predicting dishonest actions using the theory of planned behavior. J Res Pers 1991, 25(3):285-301.
29. Fishbein M. A behavior theory approach to the relations between beliefs about an object and the attitude toward the object. Readings in Attitude Theory and Measurement 1967, John Wiley, New York, NY, pp 389-399. M. Fishbein (Ed.).
30. Conner M., Armitage C.J. Extending the theory of planned behavior: a review and avenues for further research. J Appl Soc Psychol 1998, 28(15):1429-1464.
31. Fishbein M. A reasoned action approach to health promotion. Med Decis Making 2008, 28(6):834-844.
32. Parker D., Manstead A.S.R., Stradling S.G. Extending the theory of planned behavior-the role of personal norm. Br J Soc Psychol 1995, 34:127-137.
33. Manstead A.S.R., Parker D. The role of moral norms and affect in explaining behavioral intentions. I J Psychol 1996, 31(3-4). 326.
34. Herbert K.E., Urmie J.M., Newland B.A., et al. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm 2006, 2(3):299-314.
35. Nwokeji ED. Examining the Attitudes and Beliefs of Family Physicians Toward the Use of Controlled-Release Opioids for the Treatment of Chronic Non-Malignant Pain [dissertation]. Austin: College of Pharmacy, The University of Texas at Austin; 2007.
36. Randall D.M., Gibson A.M. Ethical decision-making in the medical-profession-an application of the theory of planned behavior. J Bus Ethics 1991, 10(2):111-122.
37. Werner P., Mendelsson G. Nursing staff members' intentions to use physical restraints with older people: testing the theory of reasoned action. J Adv Nurs 2001, 35(5):784-791.
38. Gorsuch R.L., Ortberg J. Moral obligation and attitudes-their relation to behavioral intentions. J Pers Soc Psychol 1983, 44(5):1025-1028.
39. Brown C.M., Barner J.C., Shah S. Community pharmacists' actions when patients use complementary and alternative therapies with medications. J Am Pharm Assoc 2005, 45(1):41-47.
40. Pradel F.G., Obeidat N.A., Tsoukleris M.G. Factors affecting pharmacists' pediatric asthma counseling. J Am Pharm Assoc 2007, 47(6):737-746.
41. Belton K.J. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997, 52(6):423-427. The European Pharmacovigilance Research Group.
42. Brown C.M., Cantu R., Corbell Z., et al. Attitudes and interests of pharmacists regarding independent pharmacy ownership. J Am Pharm Assoc 2007, 47(2):174-180.
43. Griggs S.K., Brown C.M. Texas community pharmacists' willingness to participate in pharmacist-initiated emergency contraception. J Am Pharm Assoc 2007, 47(1):48-57.
44. Olson D.S., Lawson K.A. Relationship between hospital pharmacists' job satisfaction and involvement in clinical activities. Am J Health Syst Pharm 1996, 53(3):281-284.
45. Brown C.M. Use of alternative therapies and their impact on compliance: perceptions of community pharmacists in Texas. J Am Pharm Assoc 1998, 38(5):603-608.
46. O'Donnell D.C., Brown C.M., Dastani H.B. Barriers to counseling patients with obesity: a study of Texas community pharmacists. J Am Pharm Assoc 2006, 46(4):465-471.
47. Asch D.A., Jedrziewski M.K., Christakis N.A. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997, 50(10):1129-1136.
48. Sutton S. Predicting and explaining intentions and behavior: how well are we doing?. J Appl Soc Psychol 1998, 28(15):1317-1338.
49. Conner M., Sparks P. Theory of planned behaviour and health behaviour. Predicting Health Behaviour 2005, 170-222. Open University Press, Berkshire, UK. 2nd ed. M. Conner, P. Norman (Eds.).
50. Godin G., Belanger-Gravel A., Eccles M., et al. Healthcare professionals' intentions and behaviours: a systematic review of studies based on social cognitive theories. Implement Sci 2008, 3(36):1-12.
51. Odedina F.T., Segal R. Behavioral pharmaceutical care scale for measuring pharmacists' activities. Am J Health Syst Pharm 1996, 53(8):855-865.
52. Farris K.B., Kirking D.M. Predicting community pharmacists' intention to try to prevent and correct drug therapy problems. J Soc Adm Pharm 1996, 12(2):64-78.
53. Hart S., Morris R. Screening for depression after stroke: an exploration of professionals' compliance with guidelines. Clin Rehabil 2008, 22(1):60-70.
54. O'Boyle C.A., Henly S.J., Larson E. Understanding adherence to hand hygiene recommendations: the theory of planned behavior. Am J Infect Control 2001, 29(6):352-360.
55. Walker A.E., Grimshaw J.M., Armstrong E.M. Salient beliefs and intentions to prescribe antibiotics for patients with a sore throat. Br J Health Psychol 2001, 6(4):347-360.
56. Quine L., Rutter D.R., Arnold L. Predicting and understanding safety helmet use among schoolboy cyclists: a comparison of the theory of planned behaviour and the health belief model. Psychol Health 1998, 13(2):251-269.
57. Walker A.E., Watson M., Grimshaw J.M., et al. Applying the theory of planned behaviour to pharmacists' beliefs and intentions about the treatment of vaginal candidiasis with non-prescription medicines. Fam Pract 2004, 21(6):670-676.
58. Saengcharoen W., Chongsuvivatwong V., Lerkiatbundit S., et al. Factors influencing dispensing of antibiotics for upper respiratory infections among Southern Thai community pharmacists. J Clin Pharm Ther 2008, 33(2):123-129.
59. Courneya K.S., Conner M., Rhodes R.E. Effects of different measurement scales on the variability and predictive validity of the "two-component" model of the theory of planned behavior in the exercise domain. Psychol Health 2006, 21(5):557-570.
60. Kraft P., Rise J., Sutton S., et al. Perceived difficulty in the theory of planned behaviour: perceived behavioural control or affective attitude?. Br J Soc Psychol 2005, 44:479-496.
61. Quine L., Rubin R. Attitude, subjective norm and perceived behavioural control as predictors of women's intentions to take hormone replacement therapy. Br J Health Psychol 1997, 2(3):199-216.
62. Albarracin D., Johnson B.T., Fishbein M., et al. Theories of reasoned action and planned behavior as models of condom use: a meta-analysis. Psychol Bull 2001, 127(1):142-161.
63. Bagozzi R.P. Attitudes, intentions, and behavior: a test of some key hypotheses. J Pers Soc Psychol 1981, 41(4):607-627.
64. Leone L., Perugini M., Ercolani A.P. A comparison of three models of altitude-behavior relationships in the studying behavior domain. Eur J Soc Psychol 1999, 29(2-3):161-189.
65. Bäckström M., Mjörndal T., Dahlqvist R., et al. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol 2000, 56(9):729-732.
66. Green C.F., Mottram D.R., Rowe P.H., et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001, 51(1):81-86.
67. Belton K.J., Lewis S.C., Payne S., et al. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995, 39(3):223-226.
68. Eland I.A., Belton K.J., van Grootheest A.C., et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999, 48(4):623-627.
69. Meyer G.S., Battles J., Hart J.C., et al. The US Agency for Healthcare Research and Quality's activities in patient safety research. Int J Qual Health Care 2003, 15(suppl 1):i25-i30.
70. Fried J.L., DeVore L., Dailey J. A study of Maryland dental hygienists' perceptions regarding self-assessment. J Dent Hyg 2001, 75(11):121-129.
71. Lee K.K., Chan T.Y., Raymond K., et al. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother 1994, 28(12):1400-1403.
72. Granas A.G., Buajordet M., Stenberg-Nilsen H., et al. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf 2007, 16(4):429-434.
73. Sheeran P. Intention-behavior relations: a conceptual and empirical review. European Review of Social Psychology 2002, Vol. 12:1-36. Wiley, London, UK. W. Stroebe, M. Hewstone (Eds.).
74. Webb T.L., Sheeran P. Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull 2006, 132(2):249-268.
75. Eccles M., Hrisos S., Francis J., et al. Do self-reported intentions predict clinicians' behaviour: a systematic review. Implement Sci 2006, 1(1):28.
76. Triandis H.C. Values, attitudes, and interpersonal behavior. Nebraska Symposium of Motivation 1980, Vol. 27:195-259. University of Nebraska Press, Lincoln, NE. H.E. Howe, M. Page (Eds.).
77. Wood W., Quinn J.M. Habits and the structure of motivation in everyday life. Social Motivation: Conscious and Unconscious Processes 2005, 55-70. Cambridge University Press, New York, NY. J.P. Forgas, K.D. Williams, W. Hippel (Eds.).
78. Armitage C.J., Sheeran P., Conner M., et al. Stages of change or changes of stage? Predicting transitions in transtheoretical model stages in relation to healthy food choice. J Consult Clin Psychol 2004, 72(3):491-499.
79. Sheeran P., Trafimow D., Armitage C.J. Predicting behaviour from perceived behavioural control: tests of the accuracy assumption of the theory of planned behaviour. Br J Soc Psychol 2003, 42:393-410.
80. Randall D.M., Wolff J.A. The time-interval in the intention behavior relationship-metaanalysis. Br J Soc Psychol 1994, 33(4):405-418.
81. Sheeran P., Orbell S. Do intentions predict condom use? Meta-analysis and examination of six moderator variables. Br J Soc Psychol 1998, 37:231-250.
82. Fazekas A., Senn C.Y., Ledgerwood D.M. Predictors of intention to use condoms among university women: an application and extension of the theory of planned behaviour. Can J Behav Sci 2001, 33(2):103-117.
83. Herdeiro M.T., Figueiras A., Polonia J., et al. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006, 29(4):331-340.
84. Vessal G., Mardani Z., Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 2009, 31(2):183-187.
85. Figueiras A., Tato F., Fontainas J., et al. Influence of physicians' attitudes on reporting adverse drug events: a case-control study. Med Care 1999, 37(8):809-814.
86. World Health Organization. The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products. United Kingdom: World Health Organization, The Uppsala Monitoring Centre; Geneva, Switzerland, 2002.